Clinical Trial Update: 12-Month Efficacy of Exercise and Cytisinicline for Tobacco Abstinence [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing whether combining exercise with cytisinicline yields 12-month smoking abstinence. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Cytisinicline

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Smoking Cessation | Phase 4 | Status: NOT_YET_RECRUITING